Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease — Stella

Home/Sickle Cell Disease/

View on ClinicalTrials.gov

Recruiting

Back to Sickle Cell Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Grady Health System, Atlanta, Georgia

Key details

Phase

Post-approval study

Sponsor

Emory University

Enrollment target

~50 participants

Started

April 2026

Primary completion

May 2028

Age range

18 Years and older

Sex

Female only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.